Login / Signup
Letter: ustekinumab for the treatment of post-surgical and refractory Crohn's disease.
Antonio Tursi
Giammarco Mocci
Marcello Picchio
Walter Elisei
Giovanni Maconi
Published in:
Alimentary pharmacology & therapeutics (2021)
Keyphrases
</>